Skip to ContentSkip to Navigation
University of Groningenfounded in 1614  -  top 100 university
About us Practical matters How to find us dr. W.T. van Haaften
University Medical Center Groningen

dr. W.T. van Haaften

No picture available
E-mail:
w.t.van.haaften umcg.nl

Publications

New Therapeutic Approach for Intestinal Fibrosis Through Inhibition of pH-Sensing Receptor GPR4

Acute teriflunomide overdose with relatively mild symptoms: A case report

The Citrullinated and MMP-degraded Vimentin Biomarker (VICM) Predicts Early Response to Anti-TNF alpha Treatment in Crohn's Disease

Intestinal stenosis in Crohn's disease shows a generalized upregulation of genes involved in collagen metabolism and recognition that could serve as novel anti-fibrotic drug targets

Long noncoding RNA H19X is a key mediator of TGF-beta-driven fibrosis

Serological Biomarkers of Tissue Turnover Identify Responders to Anti-TNF Therapy in Crohn's Disease: A Pilot Study

Biomarkers, Models and Mechanisms of Intestinal Fibrosis

Peribiliary glands are key in regeneration of the biliary epithelium after severe ischemic bile duct injury during liver transplantation

Peribiliary glands are key in regeneration of the human biliary epithelium after severe bile duct injury

The Oxysterol Synthesising Enzyme CH25H Contributes to the Development of Intestinal Fibrosis